Nelipak Healthcare Packaging Using Eastman Renew Materials for Production of Sterile Barrier Medical Device Packaging Products
Using Eastman medical-grade Eastar Renew 6763 supports Nelipak’s commitment to sustainable healthcare packaging
CRANSTON, R.I., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Nelipak®Corporation(“Nelipak”), a leading global manufacturer of rigid and flexible packaging solutions for medical device, diagnostic, pharmaceutical drug delivery, and other demanding applications, has announced it is using Eastman’s Eastar™ Renew 6763 to produce rigid thermoformed sterile barrier packaging. Nelipak is the first healthcare packaging manufacturer to use Eastar™ Renew 6763 to produce sterile barrier packaging for Class II & III medical device applications.
According to Eastman, Eastar™ Renew 6763, powered by Eastman’s innovative molecular recycling technologies, is indistinguishable from Eastar™ 6763 copolyester, with the same durability, safety and performance relied on by medical device companies for decades. The only difference is that by sourcing Eastar Renew, companies can certify that plastic waste is being diverted from landfills to produce new packaging. Currently, the goal is to divert waste volume equal to 25% of the weight of total packaging produced — with the potential to increase up to 50% by the end of 2023. The certified plastic waste diversion is achieved by allocating recycled waste plastic to Eastman Renew materials using an ISCC certified mass balance process.
Nelipak’s use of Eastar™ Renew 6763 in sterile barrier packaging products, is enabled by Nelipak’s ISCC PLUS certified facilities as well as ISCC PLUS certification at other supply chain partners. ISCC PLUS is a globally recognized third-party certification system for tracking sustainable feedstocks through the supply chain.
“The use of Eastar™ Renew 6763 in medical device packaging is an important step towards circularity for packaging in the healthcare industry,” said Pat Chambliss, CEO of Nelipak. “We are excited to work with customers on projects where this new medical-grade material can play an important role in achieving their sustainability goals.”
“Developing sustainable solutions and increasing circularity are priorities for many of our customers,” said Nic Hunt, Nelipak’s global head of sustainability. “An exciting benefit of working with Eastar Renew 6763 is the ease of adoption as a result of its performance characteristics. This can help customers accelerate projects which contribute to achieving sustainability objectives.”
Nelipak® is a leading global manufacturer of rigid and flexible packaging solutions for medical device, diagnostic, pharmaceutical drug delivery and other demanding applications. To support the development of innovative sustainable packaging solutions, Nelipak offers in-house design, prototyping, tooling, simulation, validation, laboratory, and other value-added services as well as a line of tray sealing equipment. With 1,400 employees and 11 sites globally, including 6 sites in North America (US, Costa Rica, Puerto Rico) and 5 sites in Europe (Ireland, Netherlands, UK), Nelipak is committed to delivering superior quality, service, and customer experience through world-class cleanroom manufacturing. For more information, visit www.nelipak.com.
Eastar and Eastman are trademarks of Eastman Chemical Company.
Follow us on:
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
FCB Tops 2023 WARC Rankings for Creative Effectiveness24.3.2023 21:41:59 CET | Press release
FCB awarded #1 Creative Agency & #1 Campaign for Effectiveness in WARC Effective 100 NEW YORK, March 24, 2023 (GLOBE NEWSWIRE) -- FCB was a top performer in the 2023 WARC Rankings, earning recognition as the #1 Creative Agency for Effectiveness in the WARC Effective 100, among other distinctions. Numerous FCB campaigns were honored as well, including Michelob ULTRA’s “Contract for Change,” which ranked as the #1 Campaign for Effectiveness. “Creative is the business and the business is creative. To separate the two does a disservice to the industry. We will continue to partner with our clients to create work that is both effective in the moment and impactful long term. FCB is honored that this Timely and Timeless approach to work is being recognized by WARC,” said Susan Credle, FCB Global Chair & Global CCO. In the Effective 100, FCB New York was named the #1 Creative Agency for Effectiveness, joined by two additional FCB agencies, with FCB Chicago ranking #4 and FCB Toronto ranking #7,
Ordinary and Extraordinary General Meeting of April 12, 202324.3.2023 21:30:00 CET | Press release
Montrouge, France, March 24, 2023 Ordinary and Extraordinary General Meeting of April 12, 2023 Procedures for Obtaining Information and Preparatory Documents for the General Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, will hold its Ordinary and Extraordinary General Meeting (the “General Meeting”) on April 12, 2023, at 10:00 a.m. CET at the Company’s headquarters located at 177-181 Avenue Pierre Brossolette – 92120 Montrouge, France. The preliminary notice (avis de réunion) containing the detailed agenda, draft resolutions as well as instructions to participate and vote for this General Meeting was published in the French “Bulletin des AnnoncesLégalesObligatoires (BALO)” dated March 8, 2023 (No. 2300429). The meeting notice (avis de convocation) was published in the French “Bulletin des AnnoncesLégalesObligatoires (BALO)” dated March 24, 2023 (No. 2300600) and in the legal newspaper Affiches pari
TGS: Approval of 2022 Financial Result24.3.2023 20:03:58 CET | Press release
Oslo, Norway (24 March 2023) – The Board of Directors of TGS ASA has today approved the financial statements for 2022. The financial statements were prepared in accordance with IFRS. Please see the attachment for a summary of changes from the preliminary annual accounts announced on 9 February 2023. About TGS TGS provides scientific data and intelligence to companies active in the energy sector. In addition to a global, extensive and diverse energy data library, TGS offers specialized services such as advanced processing and analytics alongside cloud-based data applications and solutions. For more information, visit TGS.com (http://www.tgs.com) or contact: Sven Børre Larsen CFO Tel: +47 90 94 36 73 E-mail: firstname.lastname@example.org Attachment TGS Annual Accounts 2022 update
Nokia Corporation: Repurchase of own shares on 24.03.202324.3.2023 20:00:00 CET | Press release
Nokia Corporation Stock Exchange Release 24 March 2023 at 21:00 EET Nokia Corporation: Repurchase of own shares on 24.03.2023 Espoo, Finland – On 24 March 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL306,0764.31CEUX7,3924.31AQEU2,6084.31TQEX6,3244.32Total322,4004.31 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023 and
Danske Bank A/S, ledende medarbejderes transaktioner24.3.2023 19:29:32 CET | pressemeddelelse
24. marts 2023 Indberetning nr. 3/2023 Ændring i aktiebesiddelser hos Danske Banks indberetningspligtige i henhold til EU-forordningen om markedsmisbrug For yderligere detaljer henvises til det vedhæftede skema, hvori transaktioner udført af personer med ledelsesansvar og personer med nær tilknytning til disse skal indberettes og offentliggøres. Kontakt: Stefan Singh Kailay, Head of Media Relations, tel. +45 45 14 14 00 Vedhæftet fil Bilag -Raija-Leena Hankonen-Nybom - køb